A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
type: MedicalStudy
description: A Randomized, Open-label, Dose-escalation to Rash Study to Assess the Effect of Tarceva in Combination With Gemcitabine on Overall Survival in Patients With Metastatic Pancreatic Cancer.
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2008-05
end date: 2012-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00652366
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Hoffmann-La Roche
study subject: Pancreatic Cancer
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Pancreatic Cancer

AI Analytics
type: Organization